108 related articles for article (PubMed ID: 4405106)
1. Properties of 1-isopropylamino-3-(4-indanoxy)-2-propanol (USVC 6524), an adrenergic -receptor blocking agent.
Marmo E; Saini RK; Caputi AP
Farmaco Prat; 1972 Dec; 27(12):661-87. PubMed ID: 4405106
[No Abstract] [Full Text] [Related]
2. CNS effects of 1-isopropylamino-3-(4-indanoxy)-2-propanol hydrochloride (USVC-6524).
Vyas DS; Madan BR
Indian J Exp Biol; 1972 Nov; 10(6):452-3. PubMed ID: 4146676
[No Abstract] [Full Text] [Related]
3. [Pharmacological study of a new adrenergic beta receptor blocking agent: 1-isopropylamino-3-(1,2,3,4-tetrahydro-1,4-ethano-5-naphthoxy)-2-propanol hydrochloride (K4423)].
Bergamaschi M; Mandelli V; Tommasini R; Turba C; Usardi MM
Boll Chim Farm; 1972 Nov; 111(11):667-87. PubMed ID: 4144099
[No Abstract] [Full Text] [Related]
4. 1-Isopropylamino-3-(4-indanoxy)-2-propanol HC1: a potent beta-adrenoreceptor antagonist.
Levy B; Wasserman M
Br J Pharmacol; 1970 May; 39(1):139-48. PubMed ID: 4392959
[TBL] [Abstract][Full Text] [Related]
5. New N-isopropyl and N-tert.-butyl-phenoxypropanolaminic derivatives having -adrenolytic, anti-arrhythmic and local anaesthetic activity.
Marmo E; Caputi AP; Saini RK
Arzneimittelforschung; 1972 Jul; 22(7):1109-17. PubMed ID: 4404342
[No Abstract] [Full Text] [Related]
6. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
Kadatz R; Diederen W
Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
[No Abstract] [Full Text] [Related]
7. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
Tachikawa S; Takenaka T
Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
[No Abstract] [Full Text] [Related]
8. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
Brunner H; Hedwall PR; Meier M
Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
[No Abstract] [Full Text] [Related]
9. Studies on local anaesthetic and antiarrhythmic actions of 1-isopropylamino-3-(4-indanoxy)-2-propanol HCI (USVC-6524), a new beta-adrenoceptor antagonist.
Madan BR; Vyas DS
Indian J Physiol Pharmacol; 1973; 17(3):227-34. PubMed ID: 4151008
[No Abstract] [Full Text] [Related]
10. Electrophysiological evaluation of anesthetic actions of some beta-adrenergic blockers on guinea-pig cardiac muscles.
Washizu Y
Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):263-9. PubMed ID: 4144372
[No Abstract] [Full Text] [Related]
11. [Efficiency of myocardial performance and oxidation of exogenous 14C-substrates under the influence of beta-receptor stimulating and blocking agents, as compared with other cardioactive drugs].
Range H; Bischoff M; Siess M
Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):432-3. PubMed ID: 4397506
[No Abstract] [Full Text] [Related]
12. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
Caputi AP; Marmo E; Saini RK
Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996
[No Abstract] [Full Text] [Related]
13. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
Nakanishi M; Imamura H; Nakamura T; Kimura T
Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
[No Abstract] [Full Text] [Related]
14. [Phenbutolol (Hoe 893d), a new highly efficient -sympatholytic agent with long action duration].
Härtfelder G; Lessenich H; Schmitt K
Arzneimittelforschung; 1972 May; 22(5):930-2. PubMed ID: 4403127
[No Abstract] [Full Text] [Related]
15. [Comparative studies on the effect of 2 beta receptor blockaders on elevated blood pressure and kidney function].
Anlauf M; Heimsoth V; Ulrych M; Bock KD
Verh Dtsch Ges Inn Med; 1969; 75():169-72. PubMed ID: 4395389
[No Abstract] [Full Text] [Related]
16. [Optical antipodes of adrenergic beta receptor blocking agent 1-(o-allyloxyphenoxy)-3-isopropylamino-2-propanol].
Meier M; Hedwall PR; Imhof P; Wilhelm M; Brunner H
Arzneimittelforschung; 1970 Dec; 20(12):1890-6. PubMed ID: 4395650
[No Abstract] [Full Text] [Related]
17. Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.
Mazurkiewicz-Kwilecki IM; Romagnoli A
J Pharm Pharmacol; 1970 Mar; 22(3):235-7. PubMed ID: 4399498
[No Abstract] [Full Text] [Related]
18. Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313.
Cheymol G; Honnorat C; Schmitt H
Eur J Pharmacol; 1972 Mar; 17(3):341-51. PubMed ID: 4401812
[No Abstract] [Full Text] [Related]
19. Cardiopulmonary actions of 1-isopropylamino-3-(3-tolyloxy)-2-propanol hydrochloride: a new adrenergic beta receptor antagonist.
Madan BR; Gupta RS; Santani DD
Indian J Med Res; 1970 Feb; 58(2):246-52. PubMed ID: 4394157
[No Abstract] [Full Text] [Related]
20. [Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
Grün G; Byon KY; Kaufmann R; Fleckenstein A
Arztl Forsch; 1972 Nov; 26(11):369-78. PubMed ID: 4404592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
